UBS Group
DNMR

UBS Group’s Danimer Scientific, Inc. DNMR Stock Holding History

UBS Group’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,283
Closed -$234K – 11115
2022
Q2 		$234K Hold
1,283
– – ﹤0.01% 4792
2022
Q1 		$301K Buy
+1,283
New +$259K ﹤0.01% 5062
2021
Q3 		– Sell
-2,625
Closed -$2.63M – 10229
2021
Q2 		$2.63M Buy
2,625
+2,500
+2,000% +$2.49M ﹤0.01% 3313
2021
Q1 		$189K Buy
+125
New +$203K ﹤0.01% 5533

Other funds holding DNMR

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

UBS Group's DNMR Position: Q4 2024 in Review

UBS Group sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 539 shares — an estimated $9.78K sold.

UBS Group first reported a position in DNMR in Q2 2020 and held it in 17 quarters. The position peaked at $5.43M in Q2 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • UBS Group reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 539 Danimer Scientific, Inc. shares in Q4 2024, an estimated $9.78K.
  • UBS Group first reported a position in Danimer Scientific, Inc. in Q2 2020 and held it in 17 quarters.
  • UBS Group's Danimer Scientific, Inc. position peaked at $5.43M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.